Abeona Therapeutics Inc. (ABEO) Social Stream
Abeona Therapeutics Inc (ABEO) Price Targets From Analysts
Use the tables below to see what analysts covering Abeona Therapeutics Inc think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 22 months, ABEO's average price target has gone down $6.43.
Over the past 51 weeks, ABEO's average upside potential has been 373.54%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
ABEO Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
ABEO's average broker recommendation rating improved by 0.08 over the prior 13 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ABEO as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, Abeona Therapeutics Inc's upside potential (average analyst target price relative to current price) is greater than 495.78% of them.
- To contextualize these metrics, consider that out of all US stocks, Abeona Therapeutics Inc's average analyst price target is higher than 10.48% of them.
- In terms of how Abeona Therapeutics Inc fares relative to Healthcare stocks, note that its variance in analysts' estimates is lower than -92.13% of that group.
- Abeona Therapeutics Inc's number of analysts covering the stock is higher than 54.89% of Healthcare stocks.
Is ABEO a Buy, Hold or Sell? See the POWR Ratings now!